REGULATORY GUIDELINES Sample Clauses

The Regulatory Guidelines clause establishes the requirement for parties to comply with all relevant laws, regulations, and official standards applicable to the agreement or its subject matter. In practice, this clause obligates each party to stay informed about and adhere to any changes in regulatory requirements, such as industry-specific rules, safety standards, or government-imposed restrictions. Its core function is to ensure legal compliance throughout the duration of the contract, thereby reducing the risk of legal penalties or contract breaches due to regulatory violations.
REGULATORY GUIDELINES. All tests used for personnel actions shall be valid and job related as required by OPM guidelines.
View SourceView Similar (4)
REGULATORY GUIDELINES. PVNA and the bargaining unit members recognize and accept that safety practices designed to provide for a safe workplace shall include but not be limited to guidelines published by the Center for Disease Control, Home Health Care Licensing Guidelines, and any and all safety rules promulgated by OSHA, WISHA, PVNA and/or Conference Committee recommendations.‌
View SourceView Similar (2)
REGULATORY GUIDELINES. World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects ▇▇▇▇://▇▇▇.▇▇▇.▇▇▇/e/policy/b3.htm Common Terminology Criteria for Adverse Events v4.0 (CTCAE) ▇▇▇▇://▇▇▇▇.▇▇▇▇▇▇.▇▇▇/protocoldevelopment/electronic_applications/ctc.htm EU directive ▇▇▇▇://▇▇.▇▇▇▇▇▇.▇▇/health/documents/eudralex/vol-10/
View Source
REGULATORY GUIDELINES. You agree to be bound by the Nacha Operating Rules and Guidelines, the Office of Foreign Assets Control, and all other applicable laws and regulatory requirements, as they may be amended, when using the Account Transfer Service.
View Source
REGULATORY GUIDELINES. You shall not violate (intentionally or unintentionally) any applicable local, state, national or international laws or regulations in connection with the Services, including but not limited to those related to intellectual property, privacy or security.
View Source
REGULATORY GUIDELINES. You shall not violate (intentionally or unintentionally) any applicable local, state, national or international laws or regulations in connection with the Services, including but not limited to those related to intellectual property, privacy or security. Screen Magic believes that Subscriber in accordance to Screen Magic services shall align with all applicable laws, regulations, regulatory and statutory guidelines, and shall be held self-responsible for uploading any valid data; including but not limited to consent data; on Screen Magic’s SMS systems. Screen Magic has incorporated a compliance feature which prevents messages to be sent to opted out numbers. Screen Magic further provides SMS way of consent management and the option to Subscriber to upload the data with consent only.
View Source
REGULATORY GUIDELINES. The Medical Center will abide by all staffing guidelines promulgated by the New Jersey Department of Health and Senior Services and consider professional guidelines standards as developed by recognized Specialty Nursing Organizations (e.g. Emergency Nurses Association, Association of Women’s Health) to further define staffing parameters.
View Source

Related to REGULATORY GUIDELINES

  • Regulatory Compliance Neither Borrower nor any of its Subsidiaries is an “investment company” or a company “controlled” by an “investment company” under the Investment Company Act of 1940, as amended. Neither Borrower nor any of its Subsidiaries is engaged as one of its important activities in extending credit for margin stock (under Regulations X, T and U of the Federal Reserve Board of Governors). Borrower and each of its Subsidiaries has complied in all material respects with the Federal Fair Labor Standards Act. Neither Borrower nor any of its Subsidiaries is a “holding company” or an “affiliate” of a “holding company” or a “subsidiary company” of a “holding company” as each term is defined and used in the Public Utility Holding Company Act of 2005. Neither Borrower nor any of its Subsidiaries has violated any laws, ordinances or rules, the violation of which could reasonably be expected to have a Material Adverse Change. Neither Borrower’s nor any of its Subsidiaries’ properties or assets has been used by Borrower or such Subsidiary or, to Borrower’s knowledge, by previous Persons, in disposing, producing, storing, treating, or transporting any hazardous substance other than in material compliance with applicable laws. Borrower and each of its Subsidiaries has obtained all consents, approvals and authorizations of, made all declarations or filings with, and given all notices to, all Governmental Authorities that are necessary to continue their respective businesses as currently conducted. None of Borrower, any of its Subsidiaries, or any of Borrower’s or its Subsidiaries’ Affiliates or any of their respective agents acting or benefiting in any capacity in connection with the transactions contemplated by this Agreement is (i) in violation of any Anti-Terrorism Law, (ii) engaging in or conspiring to engage in any transaction that evades or avoids, or has the purpose of evading or avoiding or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law, or (iii) is a Blocked Person. None of Borrower, any of its Subsidiaries, or to the knowledge of Borrower and any of their Affiliates or agents, acting or benefiting in any capacity in connection with the transactions contemplated by this Agreement, (x) conducts any business or engages in making or receiving any contribution of funds, goods or services to or for the benefit of any Blocked Person, or (y) deals in, or otherwise engages in any transaction relating to, any property or interest in property blocked pursuant to Executive Order No. 13224, any similar executive order or other Anti-Terrorism Law.

  • Information for Regulatory Compliance Each of the Company and the Depositary shall provide to the other, as promptly as practicable, information from its records or otherwise available to it that is reasonably requested by the other to permit the other to comply with applicable law or requirements of governmental or regulatory authorities.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, the Registration Statement or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”); neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.

  • Guidelines The Office of State Procurement adheres to all guidelines set forth by the State and Federal Government concerning The Americans with Disabilities Act (ADA) as well as all mandated fire codes.

  • Policies, Guidelines, Directives and Standards Either the Funder or the Ministry will give the HSP Notice of any amendments to the manuals, guidelines or policies identified in Schedule C. An amendment will be effective in accordance with the terms of the amendment. By signing a copy of this Agreement the HSP acknowledges that it has a copy of the documents identified in Schedule C.